Dystrogen Therapeutics

0 followers

‌

Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases. The company is currently testing DEC therapy for Duchenne Muscular Dystrophy.

Industries

Headquarters

Stage

Employees

Links

Org chart

Kris Siemionow

Co-Founder & CEO

Kris Siemionow

Collapse

Maria Siemionow

Founder & CSO

Teams

Founding Team

3 members

Leadership Team

3 members

Board of Directors

2 members

CEO and Executive Team

2 members

Similar companies

Coherus BioSciences

5 followers

ONI

6 followers

BioMarin Pharmaceutical

21 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Discover companies